Triethylenetetramine Pharmacology and Its Clinical Applications
نویسندگان
چکیده
منابع مشابه
Triethylenetetramine pharmacology and its clinical applications.
Triethylenetetramine (TETA), a Cu(II)-selective chelator, is commonly used for the treatment of Wilson's disease. Recently, it has been shown that TETA can be used in the treatment of cancer because it possesses telomerase inhibiting and anti-angiogenesis properties. Although TETA has been used in the treatment of Wilson's disease for decades, a comprehensive review on TETA pharmacology does no...
متن کاملAspirin: Pharmacology and Clinical Applications
Antiplatelet therapy has been documented to reduce risks of cardiovascular disease after acute myocardial infarction, coronary artery bypass graft, and in chronic atrial fibrillation patients, amongst other risk factors. Conventional management of thrombosis-based disorders includes the use of heparin, oral anticoagulants, and the preferred antiplatelet agent aspirin. Interestingly, aspirin was...
متن کاملNew Antifolates: Pharmacology and Clinical Applications.
Many new antifolate compounds with unique clinical properties are currently in clinical development. Some of these agents have been rationally designed to circumvent known mechanisms of resistance to methotrexate, the most useful and extensively studied antifolate in clinical practice. Resistance to methotrexate can result from decreased active transport into cells, decreased polyglutamation re...
متن کاملLook at the Clinical Skills Center and its applications
Clinical skills centers are one of the potentials in medical universities. Despite the huge spending in our country, these centers are used incompletely and undesirable. These review articles look at these centers, its application in some Iranian universities and foreign universities, and present some suggestions for optimal use of these centers in nationwide universities
متن کاملPemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications.
Pemetrexed is a new-generation antifolate, approved for the treatment of mesothelioma and non-small cell lung cancer, currently being evaluated for the treatment of a variety of other solid tumors. This review traces the history of antifolates that led to the development of pemetrexed and describes the unique properties of this agent that distinguish it from other antifolates. These include (a)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Cancer Therapeutics
سال: 2010
ISSN: 1535-7163,1538-8514
DOI: 10.1158/1535-7163.mct-10-0523